A multitope SARS-CoV-2 vaccine provides long-lasting B cell and T cell immunity against Delta and Omicron variantsChang Yi Wang, Thomas P. Monath, Farshad Guirakhoo et al.|DOAJ (DOAJ: Directory of Open Access Journals)|2022Cited by 76
Nirmatrelvir-ritonavir significantly reduces severe COVID-19 outcomes in diverse Taiwanese populations: Comprehensive evidence from a large-scale longitudinal cohort study in TaiwanFu‐Der Wang, Jason C. Hsu, Mei-Hui Lee et al.|Journal of Infection and Public Health|2025Cited by 0